Table 1.
Type of vascular access for HD created in the pre-COVID and COVID period and CVC prevalence in incident and prevalent HD patients
| Type of access | Pre-COVID period | COVID period | P-value |
|---|---|---|---|
| Consecutive VA created, n (%) |
930 VA |
861 VA |
<0.001 |
| CVC | 555 (59.7) | 598 (69.5) | |
| AVF | 321 (34.5) | 224 (26) | |
| AVG | 54 (5.8) | 39 (4.5) | |
| VA in incident HD patients, n (%) |
447 patients |
458 patients |
<0.001 |
| CVC | 309 (69.1) | 368 (80.3) | |
| AVF | 131 (29.3) | 81 (17.7) | |
| AVG | 7 (1.9) | 9 (2) | |
| VA in prevalent HD patients, n (%) |
1083 patients |
1343 patients |
<0.001 |
| CVC | 372 (34.4) | 494 (36.83) | |
| AVF | 663 (61.2) | 804 (59.8) | |
| AVG | 48 (4.4) | 45 (3.3) |